2nd Jul 2020 17:54
Oxford Biomedica PLC - gene and cell therapy group - Vulpes Testudo Fund, closely associated with Non-Executive Director Martin Diggle, has purchased 8,181 ordinary shares at 719.6 pence per share, worth GBP58,821 in total. Following the purchase, Vulpes holds 11.5 million ordinary shares, representing 14.0% of the company.
Current stock price: 736.00 pence
Year-to-date change: down 9.4%
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica